Titre : Hépatite chronique

Hépatite chronique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hépatite chronique : Questions médicales les plus fréquentes", "headline": "Hépatite chronique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hépatite chronique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-22", "dateModified": "2025-02-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hépatite chronique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie chronique", "url": "https://questionsmedicales.fr/mesh/D002908", "about": { "@type": "MedicalCondition", "name": "Maladie chronique", "code": { "@type": "MedicalCode", "code": "D002908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hépatite B chronique", "alternateName": "Hepatitis B, Chronic", "url": "https://questionsmedicales.fr/mesh/D019694", "about": { "@type": "MedicalCondition", "name": "Hépatite B chronique", "code": { "@type": "MedicalCode", "code": "D019694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.500" } } }, { "@type": "MedicalWebPage", "name": "Hépatite C chronique", "alternateName": "Hepatitis C, Chronic", "url": "https://questionsmedicales.fr/mesh/D019698", "about": { "@type": "MedicalCondition", "name": "Hépatite C chronique", "code": { "@type": "MedicalCode", "code": "D019698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.750" } } }, { "@type": "MedicalWebPage", "name": "Hépatite D chronique", "alternateName": "Hepatitis D, Chronic", "url": "https://questionsmedicales.fr/mesh/D019701", "about": { "@type": "MedicalCondition", "name": "Hépatite D chronique", "code": { "@type": "MedicalCode", "code": "D019701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Hépatite chronique", "alternateName": "Hepatitis, Chronic", "code": { "@type": "MedicalCode", "code": "D006521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Heiner Wedemeyer", "url": "https://questionsmedicales.fr/author/Heiner%20Wedemeyer", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany." } }, { "@type": "Person", "name": "Grace Lai-Hung Wong", "url": "https://questionsmedicales.fr/author/Grace%20Lai-Hung%20Wong", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Giuseppina Brancaccio", "url": "https://questionsmedicales.fr/author/Giuseppina%20Brancaccio", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy." } }, { "@type": "Person", "name": "Giovanni B Gaeta", "url": "https://questionsmedicales.fr/author/Giovanni%20B%20Gaeta", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it." } }, { "@type": "Person", "name": "Maria Buti", "url": "https://questionsmedicales.fr/author/Maria%20Buti", "affiliation": { "@type": "Organization", "name": "Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Crystallization of Amorphous Nifedipine Under Isothermal Conditions: Inter-laboratory Reproducibility and Investigation of the Factors Affecting Reproducibility.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37301322", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.xphs.2023.06.002" } }, { "@type": "ScholarlyArticle", "name": "Considerations for reproducible omics in aging research.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37386258", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s43587-023-00448-4" } }, { "@type": "ScholarlyArticle", "name": "The UK Reproducibility Network: A progress report.", "datePublished": "2023-08-14", "url": "https://questionsmedicales.fr/article/37586662", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jneumeth.2023.109949" } }, { "@type": "ScholarlyArticle", "name": "Reproducibility in Neuroimaging Analysis: Challenges and Solutions.", "datePublished": "2022-12-19", "url": "https://questionsmedicales.fr/article/36906444", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bpsc.2022.12.006" } }, { "@type": "ScholarlyArticle", "name": "Advances in transparency and reproducibility in the social sciences.", "datePublished": "2022-07-12", "url": "https://questionsmedicales.fr/article/36058608", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ssresearch.2022.102770" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Caractéristiques de la maladie", "item": "https://questionsmedicales.fr/mesh/D020969" }, { "@type": "ListItem", "position": 5, "name": "Maladie chronique", "item": "https://questionsmedicales.fr/mesh/D002908" }, { "@type": "ListItem", "position": 6, "name": "Hépatite chronique", "item": "https://questionsmedicales.fr/mesh/D006521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hépatite chronique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hépatite chronique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hépatite chronique", "description": "Comment diagnostiquer l'hépatite chronique ?\nQuels tests sanguins sont utilisés ?\nQu'est-ce qu'une biopsie hépatique ?\nQuels sont les signes d'hépatite chronique ?\nL'échographie est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hépatite chronique", "description": "Quels sont les symptômes courants ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des symptômes psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hépatite chronique", "description": "Comment prévenir l'hépatite chronique ?\nLa vaccination est-elle efficace ?\nQuels comportements à risque éviter ?\nL'hygiène joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hépatite chronique", "description": "Quels traitements existent pour l'hépatite chronique ?\nLes antiviraux sont-ils efficaces ?\nQuand faut-il envisager une transplantation ?\nY a-t-il des traitements naturels ?\nComment surveiller l'évolution de la maladie ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hépatite chronique", "description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nQuels signes indiquent une insuffisance hépatique ?\nLe cancer du foie est-il fréquent ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hépatite chronique", "description": "Quels sont les principaux facteurs de risque ?\nL'usage de drogues augmente-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes voyages à l'étranger sont-ils un risque ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Reproducibility+of+Results&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hépatite chronique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique." } }, { "@type": "Question", "name": "Qu'est-ce qu'une biopsie hépatique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions." } }, { "@type": "Question", "name": "Quels sont les signes d'hépatite chronique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons." } }, { "@type": "Question", "name": "L'échographie est-elle utile ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes asymptomatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir l'hépatite chronique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels." } }, { "@type": "Question", "name": "La vaccination est-elle efficace ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections." } }, { "@type": "Question", "name": "Quels comportements à risque éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues." } }, { "@type": "Question", "name": "L'hygiène joue-t-elle un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hépatite chronique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien." } }, { "@type": "Question", "name": "Les antiviraux sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique." } }, { "@type": "Question", "name": "Quand faut-il envisager une transplantation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin." } }, { "@type": "Question", "name": "Comment surveiller l'évolution de la maladie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique." } }, { "@type": "Question", "name": "La cirrhose est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie." } }, { "@type": "Question", "name": "Quels signes indiquent une insuffisance hépatique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal." } }, { "@type": "Question", "name": "Le cancer du foie est-il fréquent ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "L'usage de drogues augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale." } }, { "@type": "Question", "name": "Les voyages à l'étranger sont-ils un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Crystallization of Amorphous Nifedipine Under Isothermal Conditions: Inter-laboratory Reproducibility and Investigation of the Factors Affecting Reproducibility.

High inter-laboratory reproducibility is required for conducting collaborative experiments among several laboratories. The primary aim of our evaluation of the physical stability of amorphous drugs, c...

Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.

To evaluate anatomical and volumetric predictability of a cone beam computed tomography (CBCT)-based virtual parenchymal perfusion (VPP) software for the single-photon-emission computed tomography (SP... VPP was evaluated retrospectively on CBCT data of patients treated by TARE for HCC.... Fifty-two CBCTs were performed in 33 included patients. Semi-quantitative evaluation showed a good concordance between actual... CBCT-based VPP software is accurate and reliable to predict... • Virtual parenchymal perfusion (VPP) software is accurate and reliable in the prediction of...

Interexaminer reproducibility for subjective refractions for an ametropic participant.

To investigate interexaminer reproducibility of non-cycloplegic subjective refractions. Subjective refractions are frequently determined, and it is important to know whether differences in refractive ... Fifty registered and experienced (≥5 years) optometrists from a single geographic region performed non-cycloplegic subjective refractions for a participant with moderate left eye(OS) to severe right e... Mean subjective refractions were -7.68-4.50×10 and -4.59-1.85×178 for the right and left eyes, respectively. The 95% absolute reproducibility limits for the stigmatic coefficients (spherical equivalen... Removal of possible outliers for OD and OS, respectively, reduces the absolute 95% reproducibility limits for the stigmatic and astigmatic coefficients to ≤0.97 D and ≤0.49 D, thus improving interexam...